|
|
Office Locations:
|
701 Minnesota Street, Unit #113
San Francisco, CA 94107
| |
|
|
|
|
|
|
Energy & Clean Tech
Information Technology
Life Sciences & Healthcare
Medical Device
|
|
|
|
With more than $250 million under management, Birchmere Ventures invests in early-stage cleantech, medical, technology and life sciences companies. Founded in 1996, Birchmere focuses principally on early stage, pre-revenue start-ups where the firm has direct operational or investing experience. Target companies are founded by entrepreneurs with deep domain expertise who are developing revolutionary innovations that sell into existing markets. The firm's investment team comprises technologists with strong operating and venture investing experience and partners with companies from launch to exit, helping them to minimize risk and maximize opportunity. Birchmere has made over 50 investments.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
